Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001552 | OXALIC ACID (M-H) | 87.9800 | 0.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 88.0166 | 0.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | OXALACETIC ACID (M-H-H2O) | 93.9668 | 0.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 99.9253 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 2-HYDROXYBUTYRIC ACID (M-H) | 102.0315 | 1.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 114.0314 | 2.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | ACETYLGLYCINE (M-H) | 115.0265 | 0.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | L-VALINE (M-H) | 115.0623 | 0.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 5-AMINOPENTANOIC ACID (M-H) | 115.0625 | 0.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 115.9197 | 22.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 116.0105 | 1.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | SUCCINIC ACID (M-H) | 116.0105 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 116.0469 | 2.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 116.0470 | 3.03 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 2-HYDROXY-3-METHYLBUTYRIC ACID (M-H) | 116.0472 | 3.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | TAURINE (M-H) | 122.9988 | 0.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | PYROGLUTAMIC ACID (M-H) | 127.0265 | 1.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 127.0268 | 0.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 3-METHYL-2-OXOVALERIC ACID (M-H) | 128.0473 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | KETOLEUCINE (M-H) | 128.0473 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | N-ACETYL-L-ALANINE (M-H) | 129.0416 | 1.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | L-ISOLEUCINE (M-H) | 129.0779 | 1.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | GLUTARIC ACID (M-H) | 130.0258 | 2.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 130.0625 | 5.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 130.0625 | 6.24 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 130.0625 | 6.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | MALIC ACID (M-H) | 132.0060 | 0.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 133.8837 | 23.1 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 133.8851 | 22.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 133.9817 | 0.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | HYPOXANTHINE (M-H) | 134.0222 | 1.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 136.0160 | 8.36 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 2-AMINOBENZOIC ACID (M-H) | 136.0285 | 5.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 143.9144 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 143.9146 | 23.31 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | ADIPIC ACID (M-H) | 144.0416 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 144.0422 | 2.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | L-GLUTAMINE (M-H) | 144.0537 | 0.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 145.9744 | 0.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 146.0197 | 1.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | CITRAMALIC ACID (M-H) | 146.0201 | 1.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 146.0361 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 147.9420 | 0.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | XANTHINE (M-H) | 150.0170 | 1.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 150.0310 | 7.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 152.0100 | 4.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 152.8597 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | L-HISTIDINE (M-H) | 153.0535 | 0.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 156.0779 | 12.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 157.9699 | 0.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 158.0935 | 13.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 158.0937 | 11.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | L-PHENYLALANINE (M-H) | 163.0629 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 164.0233 | 7.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 1-METHYLXANTHINE (M-H) | 164.0334 | 2.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 164.0463 | 7.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 164.0828 | 16.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | URIC ACID (M-H) | 166.0126 | 0.99 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 167.9807 | 5.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 169.0646 | 15.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 170.0181 | 1.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 170.0571 | 8.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 170.0935 | 11.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | N-ACETYLLEUCINE (M-H) | 171.0885 | 7.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 171.0889 | 5.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 171.9829 | 3.09 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 172.0727 | 8.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 172.0837 | 1.4 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 173.0473 | 8.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 174.0031 | 3.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | HIPPURIC ACID (M-H) | 177.0422 | 4.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | ASPIRIN (M-H) | 178.0276 | 8.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 178.0392 | 5.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 178.0400 | 6.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | THEOPHYLLINE (M-H) | 178.0480 | 4.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | L-TYROSINE (M-H) | 179.0575 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 179.0939 | 14.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 179.9642 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 1-METHYLURIC ACID (M-H) | 180.0269 | 2.22 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | HYDROXYPHENYLLACTIC ACID (M-H) | 180.0416 | 3.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 4-PYRIDOXIC ACID (M-H) | 181.0367 | 1.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 182.1299 | 16.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 184.0341 | 3.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 184.0472 | 1.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 184.0890 | 15.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 184.1092 | 15.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 184.9849 | 1.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 185.0470 | 4.16 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 185.1047 | 7.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 185.9987 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.0054 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.0057 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.0333 | 0.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.0334 | 0.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.0884 | 8.66 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.0886 | 10.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.1249 | 17.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 186.1250 | 16.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 187.0362 | 1.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 187.0627 | 10.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 187.0827 | 0.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 187.9777 | 2.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 188.0678 | 7.66 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 5-HYDROXYINDOLEACETIC ACID (M-H) | 189.0448 | 4.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | CITRIC ACID (M-H) | 190.0106 | 1.01 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | ISOCITRIC ACID (M-H) | 190.0109 | 0.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 190.8517 | 22.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 192.0780 | 15.24 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 193.9865 | 5.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 1,7-DIMETHYLURIC ACID (M-H) | 194.0424 | 4.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 194.0452 | 6.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 194.1299 | 20.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 194.8028 | 0.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 195.0133 | 1.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 196.0342 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 196.0342 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 196.0726 | 9.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 196.1456 | 21.32 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 197.0654 | 1.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 197.9983 | 7.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 198.1248 | 15.37 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DODECANOIC ACID (M-H) | 198.1612 | 21.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 199.1202 | 10.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 200.0138 | 8.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 200.0293 | 0.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 200.1045 | 13.1 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 200.1405 | 17.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 201.0995 | 1.86 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 201.9931 | 4.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 201.9932 | 3.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 202.0473 | 3.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | L-TRYPTOPHAN (M-H) | 202.0741 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 203.0576 | 8.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 203.0578 | 7.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 204.0159 | 5.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | N-ACETYL-L-PHENYLALANINE (M-H) | 205.0732 | 7.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | L-KYNURENINE (M-H) | 206.0678 | 2.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 208.0856 | 13.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 210.9935 | 4.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 210.9940 | 3.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 211.9711 | 5.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.0075 | 7.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.0112 | 9.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.0128 | 1 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.1040 | 13.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.1406 | 18.23 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.1406 | 18.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 212.8804 | 0.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 213.1358 | 12.38 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 213.9825 | 0.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 214.0237 | 2.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 214.0252 | 1.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 214.1201 | 15.01 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 214.1563 | 19.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 216.0625 | 5.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | O-SUCCINYL-L-HOMOSERINE (M-H) | 217.0573 | 0.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | PANTOTHENIC ACID (M-H) | 217.0945 | 3.31 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | CIS-ZEATIN (M-H) | 217.0960 | 3.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 217.9865 | 3.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 5-HYDROXY-L-TRYPTOPHAN (M-H) | 218.0674 | 1.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 220.0727 | 14.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 220.0839 | 3.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 220.1458 | 20.35 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 221.0214 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 221.1044 | 13.65 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 222.1612 | 21.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 223.9711 | 1 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | MYRISTOLEIC ACID (M-H) | 224.1769 | 22.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 225.9593 | 0.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 226.0270 | 11.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 226.1198 | 15.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | MYRISTIC ACID (M-H) | 226.1927 | 22.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 226.8959 | 1.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 227.1515 | 14.28 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 228.0060 | 8.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 228.0447 | 12.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 228.0602 | 1.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 228.0614 | 1.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 228.0779 | 15.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 228.1358 | 16.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 229.0039 | 5.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 229.0040 | 2.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 229.1040 | 1.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 229.9877 | 6.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 231.0502 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 231.9870 | 7.31 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 233.9989 | 1.01 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 2-DEOXYGLUCOSE (M+Cl) | 234.0063 | 0.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 235.0005 | 4.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 235.0840 | 2.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 236.1402 | 18.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 237.0164 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 238.0501 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 238.0587 | 19.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 238.0838 | 15.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 238.1351 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 238.1352 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 238.1563 | 19.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 239.0399 | 0.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 239.1630 | 21.81 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 239.9716 | 3.09 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 240.1101 | 6.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 240.1356 | 16.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 240.1718 | 20.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 240.1721 | 20.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 240.2081 | 22.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 241.1675 | 15.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 242.0531 | 0.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | URIDINE (M-H) | 242.0533 | 1.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 242.1517 | 18.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 242.1623 | 6.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 242.1873 | 21.81 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 242.1876 | 21.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 243.1292 | 16.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 243.8998 | 13.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 243.9610 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 244.0377 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 244.0383 | 6.14 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 244.0410 | 9.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 244.1050 | 2.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 244.1198 | 4.16 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 245.0294 | 4.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 246.0045 | 3.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 247.0444 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 247.0473 | 4.22 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 247.9525 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 248.1766 | 20.12 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 248.1767 | 22.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 249.1360 | 21.14 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | D-GLUCOSE (M+Cl) | 250.0016 | 0.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 250.0853 | 15.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 250.1191 | 16.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 250.1925 | 22.31 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 251.0363 | 6.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 252.1254 | 23.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 252.1329 | 16.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 252.1353 | 17.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 252.1354 | 15.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | PALMITOLEIC ACID (M-H) | 252.2089 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 253.0922 | 7.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 253.9201 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 253.9201 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 253.9861 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 254.0786 | 10.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 254.1048 | 11.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 254.1051 | 12.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 254.1255 | 8.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 254.1512 | 17.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 254.1512 | 18.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | PALMITIC ACID (M-H) | 254.2247 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 254.9515 | 1.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 256.0625 | 5.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 256.0915 | 3.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 256.1672 | 18.74 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 256.1672 | 19.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 256.2030 | 22.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 258.0029 | 4.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 258.0034 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 258.1211 | 4.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 259.0147 | 1.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 259.9851 | 0.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 260.0328 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 260.0769 | 3.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 262.0954 | 5.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 262.1198 | 14.37 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 263.1014 | 3.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 263.9800 | 0.99 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 264.1356 | 17.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 264.1395 | 21.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 264.9802 | 1.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 265.9872 | 5.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | INOSINE (M-H) | 266.0650 | 1.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 266.1156 | 18.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 266.1490 | 21.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 266.1876 | 21.37 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 266.2240 | 22.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 268.0787 | 0.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 268.1417 | 10.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 268.2030 | 21.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 268.2031 | 21.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 268.2032 | 21.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | HEPTADECANOIC ACID (M-H) | 268.2395 | 23 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 268.9525 | 3.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 269.1371 | 2.86 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 270.0615 | 3.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 270.2184 | 21.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 270.2187 | 21.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 270.2190 | 21.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 270.2190 | 22.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 271.1780 | 16.22 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 272.1155 | 11.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 272.1155 | 11.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 272.2028 | 22.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 273.9719 | 15.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 274.0948 | 3.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 274.1564 | 20.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 274.1904 | 22.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 275.1518 | 21.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 276.1374 | 20.14 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 276.1470 | 7.81 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 276.1716 | 19.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 276.2090 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 277.1158 | 0.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 278.0268 | 0.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 278.0900 | 3.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 278.1878 | 20.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | LINOLEIC ACID (M-H) | 278.2250 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 278.9812 | 3.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 279.9861 | 7.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 280.0921 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 280.0921 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | OLEIC ACID (M-H) | 280.2406 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 281.9301 | 0.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.0938 | 1.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.0997 | 23.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.1102 | 13.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.1248 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.1249 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.1524 | 1.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.1825 | 20.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 282.2400 | 22.66 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | STEARIC ACID (M-H) | 282.2560 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 282.9939 | 2.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 283.2145 | 21.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 283.2591 | 24.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 284.1982 | 20.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 284.1985 | 21.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 284.2343 | 22.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 285.0835 | 3.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 286.1133 | 19.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 286.1262 | 1.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 287.1193 | 12.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 287.8701 | 0.93 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 287.8709 | 1.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 288.0578 | 14.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 288.0588 | 1.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 288.0990 | 18.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 288.8894 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 288.8897 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 288.9359 | 2.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | CIS-ZEATIN (M+Cl) | 289.0495 | 3.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 290.2005 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 291.1320 | 1.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 292.1055 | 5.09 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 292.1669 | 17.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 292.1673 | 17.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 292.1704 | 27.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 292.2028 | 21.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 293.0217 | 2.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 293.1753 | 16.23 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 293.9463 | 0.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.0553 | 8.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.1829 | 22.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.2185 | 21.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.2186 | 22 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.2189 | 21.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.2548 | 23.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 294.9755 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 295.0548 | 0.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.0550 | 5.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.0630 | 15.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.1167 | 16.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.1169 | 23.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.1437 | 22.81 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.1440 | 22.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.1441 | 22.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.2336 | 22.16 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.2341 | 21.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.2345 | 21.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.2698 | 23.38 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 296.9989 | 0.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DEOXYURIDINE (M+Cl) | 298.0112 | 1.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 298.0611 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.0816 | 6.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.0821 | 5.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.0858 | 21.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.0948 | 12.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.2146 | 21.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.2155 | 22.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.2491 | 22.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.2500 | 22.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 298.2501 | 22.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 299.0371 | 2.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 299.1913 | 18.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 300.1110 | 18.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 300.2086 | 22.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 300.2298 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 301.9982 | 9.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | ARACHIDONIC ACID (M-H) | 302.2250 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 303.1070 | 2.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 304.2400 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DUMP (M-H) | 306.0257 | 0.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 306.0677 | 15.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 306.1940 | 22.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 306.2552 | 23.02 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 307.0504 | 0.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 307.0885 | 0.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 308.0913 | 13.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 308.0915 | 15.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 308.1101 | 3.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 308.1612 | 17.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 308.1618 | 17.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 308.1984 | 21.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | EICOSENOIC ACID (M-H) | 308.2710 | 23.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 309.1551 | 15.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.0400 | 1.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.1324 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.1660 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.2121 | 19.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.2138 | 21.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.2139 | 20.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 310.2848 | 23.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | ARACHIDIC ACID (M-H) | 310.2860 | 23.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 311.2452 | 22.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.0276 | 9.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1100 | 15.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1105 | 13.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1105 | 14.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1106 | 14.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1129 | 18.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1235 | 7.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.1836 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.2268 | 22.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.2291 | 20.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.2292 | 21.97 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 312.2294 | 22.24 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 313.0914 | 0.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 313.9818 | 15.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | URIDINE (M+Cl) | 314.0074 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 314.1548 | 21.4 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 314.1721 | 17.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 314.2010 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 314.2448 | 20.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 314.2453 | 21.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 315.9407 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 315.9580 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 316.1053 | 11.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 316.1057 | 10.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 316.1057 | 11.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 316.2058 | 21.97 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 316.2169 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 317.0368 | 0.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 318.2192 | 21.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 318.2318 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 318.2475 | 22.23 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 320.0533 | 5.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 320.1292 | 17.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 320.1965 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 320.2339 | 22.33 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 321.1996 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 322.1073 | 16.38 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 322.2119 | 22.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 323.2195 | 22.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 323.9057 | 2.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 324.0714 | 18.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 324.2262 | 21.93 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | ACETAMINOPHEN GLUCURONIDE (M-H) | 325.0799 | 2.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 325.1164 | 2.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 326.0874 | 2.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 326.0879 | 17.02 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 326.1181 | 22.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 326.1587 | 2.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DOCOSAHEXAENOIC ACID (M-H) | 326.2250 | 22.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 326.2492 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 327.1086 | 1.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 327.1431 | 5.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.1185 | 21.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.1296 | 15.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.1434 | 17.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.1812 | 14.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.2239 | 16.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.2401 | 22.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 328.2609 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 329.0875 | 4.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.0828 | 5.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.1214 | 11.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.1217 | 12.23 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.1442 | 13.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.1472 | 15.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.1674 | 16.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.2403 | 18.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 330.2556 | 22.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 331.0892 | 3.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 331.2264 | 20.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 331.9137 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 332.0847 | 1.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 332.1263 | 21.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 332.1963 | 21.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 332.1983 | 19.28 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 332.2702 | 23.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 334.1024 | 18.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 334.1676 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 334.2122 | 22.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 334.2132 | 19.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 334.2251 | 22.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 335.0640 | 6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 336.1830 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 336.2269 | 21.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 336.2283 | 19.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | ERUCIC ACID (M-H) | 336.3023 | 23.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 337.0799 | 6.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | INOSINE (M+Cl) | 338.0173 | 1.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 338.0471 | 3.65 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 338.0498 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 338.1978 | 22.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 338.1987 | 22.74 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 338.2070 | 22.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 338.2439 | 22.16 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | BEHENIC ACID (M-H) | 338.3178 | 24.14 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 339.1322 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 339.8892 | 0.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 340.2050 | 22.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 340.2144 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 340.9521 | 3.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 341.1104 | 1.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 341.2568 | 20.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 341.2589 | 22.32 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.0427 | 0.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.0620 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.0622 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.0749 | 12.1 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.1173 | 3.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.2034 | 19.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 342.2209 | 21.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 343.1257 | 2.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 343.9761 | 13.37 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1267 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1267 | 7.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1272 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1336 | 7.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1369 | 14.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1616 | 15.13 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.1966 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 344.2334 | 21.09 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.1046 | 5.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.1086 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.1420 | 12.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.1427 | 9.03 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.1770 | 14.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.2121 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 346.2495 | 21.93 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 348.0053 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 348.0774 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 348.0777 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 348.2277 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 349.0904 | 1.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 349.1423 | 8.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 349.2372 | 19.97 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.0637 | 18.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.0687 | 1.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.1241 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.1613 | 14.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.2417 | 24.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.2425 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 350.2437 | 22.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 352.1017 | 12.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 352.1022 | 12.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 352.1335 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 352.2603 | 22.38 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | TRICOSANOIC ACID (M-H) | 352.3334 | 24.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 352.3338 | 24.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 354.1335 | 22.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 354.1497 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 354.1987 | 21.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 354.2586 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 354.2757 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 354.2765 | 23.22 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 356.0235 | 0.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 356.0799 | 18.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 356.0898 | 13.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 356.1494 | 22.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 356.2541 | 21.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 356.2707 | 23.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 357.2508 | 17.74 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 357.2511 | 19.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 357.2512 | 17.24 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 358.0244 | 5.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 358.0667 | 12.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 358.1822 | 20.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 358.2862 | 23.26 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 359.1192 | 1.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 359.2586 | 22.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 359.2671 | 19.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 359.2671 | 19.97 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 360.0864 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 360.0973 | 1.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 360.1211 | 5.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 360.1212 | 6.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 360.1540 | 17.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 360.1827 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 361.0930 | 2.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 361.9332 | 0.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 362.1043 | 5.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 362.1363 | 5.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 362.1994 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 362.2442 | 22.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 362.2447 | 22.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 362.3176 | 23.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.1267 | 2.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.1273 | 3.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.1334 | 14.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.2190 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.2229 | 21.81 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.2602 | 22.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 364.2609 | 22.23 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | NERVONIC ACID (M-H) | 364.3335 | 24.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 366.0687 | 5.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 366.1499 | 16.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 366.1503 | 17.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 366.1516 | 15.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 366.3491 | 24.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | TETRACOSANOIC ACID (M-H) | 366.3494 | 24.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 367.9634 | 3.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.0904 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.1651 | 17.28 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.1656 | 14.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.1658 | 18.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.1659 | 17.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.1667 | 16.36 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.1668 | 17.4 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.2312 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.2883 | 23.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 368.3238 | 22.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 370.1803 | 15.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 370.1812 | 16.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 370.1820 | 19.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 370.2139 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 370.3057 | 22.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 371.0952 | 1.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 371.1081 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 371.1322 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 372.0058 | 0.99 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 373.1242 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 373.9982 | 9.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.1113 | 12.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.1218 | 22.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.1579 | 6.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.1756 | 18.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.2439 | 22.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.2457 | 22.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 374.9967 | 0.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 375.2609 | 17.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 375.2619 | 16.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 376.0362 | 0.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 376.1268 | 8.03 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 376.1324 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 376.1518 | 9.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 376.3316 | 23.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 377.0870 | 1.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 377.2385 | 21.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 378.0770 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 378.0828 | 4.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 378.1194 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 378.1499 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.0143 | 9.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.0217 | 0.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.0658 | 9.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.0669 | 9.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.1030 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.1041 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.1658 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.2471 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.2515 | 22.74 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.2521 | 22.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 380.3645 | 24.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 381.0290 | 1.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1141 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1186 | 9.03 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1449 | 11.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1449 | 13.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1459 | 13.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1648 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.1811 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.2778 | 22.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.3070 | 23.28 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 382.9764 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 383.0751 | 2.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 383.9287 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 383.9483 | 5.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1585 | 11.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1594 | 13.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1606 | 13.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1607 | 11.4 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1608 | 15.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1611 | 11.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.1818 | 22.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.2287 | 18.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.2497 | 22.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 384.3219 | 22.65 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.1746 | 15.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.1748 | 12.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.1752 | 14.31 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.1759 | 14.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.2070 | 21.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.2449 | 22.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 386.2767 | 19.1 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 388.0817 | 11.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 388.1772 | 1.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 388.1814 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 388.2452 | 22.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 389.1286 | 0.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.0395 | 0.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.1069 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.1316 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.2639 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.2751 | 19.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.2760 | 20.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 390.2768 | 21.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DEOXYCHOLIC ACID (M-H) | 390.2770 | 21.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | HYODEOXYCHOLIC ACID (M-H) | 390.2795 | 22.87 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 390.4123 | 21.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DEOXYCHOLIC ACID (2M-H) | 391.2829 | 21.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 392.0527 | 5.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 392.2706 | 22.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 392.2882 | 22.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 392.3644 | 24.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 393.1037 | 2.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 393.9757 | 15.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 394.1816 | 18.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 394.2123 | 22.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 394.2989 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 394.3798 | 25.47 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 394.3804 | 25.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 395.9956 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.0976 | 6.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.1608 | 15.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.1705 | 13.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.1961 | 16.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.1972 | 19.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.1984 | 17.65 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.2143 | 20.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.2293 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.3196 | 22.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.3229 | 23.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.3238 | 22.99 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 396.3590 | 23.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 397.1243 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 397.1457 | 22.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.1082 | 12.24 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.1429 | 12.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.1770 | 18.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.2123 | 18.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.2126 | 19.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.2666 | 22.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 398.3201 | 22.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 399.0692 | 1.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 399.1400 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 399.1472 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 399.1613 | 23.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 399.9016 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 400.1037 | 3.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 400.1922 | 17.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 400.2802 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 401.1554 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 401.2909 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.0656 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.0844 | 7.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.0848 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.0851 | 8.64 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.1477 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.2977 | 24.29 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 402.2980 | 22.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 404.0981 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 404.1002 | 9.03 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 404.1589 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 404.1836 | 13.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 404.2562 | 21.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 404.2913 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 406.1140 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 406.1645 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 406.1987 | 12.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 406.1997 | 13.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 406.2717 | 20.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 406.3374 | 22.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 407.1218 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 408.0828 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 408.1297 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 408.1795 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 408.3195 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.0495 | 4.79 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.0497 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.0539 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.1507 | 14.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.1761 | 16.36 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.1764 | 14.38 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.1939 | 19.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.1944 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.2862 | 22.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.3379 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 410.3755 | 23.21 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 411.1157 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 411.1794 | 11.09 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.0947 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1136 | 7.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1139 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1144 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1288 | 9.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1852 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1907 | 13.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1912 | 15.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1921 | 15.74 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.1930 | 16.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.2085 | 23.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 412.3516 | 22.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 413.9817 | 0.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 413.9818 | 0.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.1057 | 22.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.1296 | 9.03 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.1888 | 15.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.1940 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.2056 | 16.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.2070 | 18.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.2070 | 18.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.2753 | 22.54 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 414.3079 | 22.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 415.1707 | 2.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 415.3293 | 21.95 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 416.1189 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 416.2039 | 17.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 416.2097 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 416.2925 | 22.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 416.2927 | 22.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 417.1590 | 1.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 418.0380 | 2.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 418.1039 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 418.2274 | 23.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 418.6383 | 22.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 419.7151 | 22.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 420.1527 | 23.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 420.1788 | 14.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 420.3199 | 24.11 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 420.3235 | 22.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 420.3541 | 22.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 421.1241 | 22.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 422.0856 | 3.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 422.3392 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 423.1276 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 423.1406 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 424.1084 | 15.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 424.1378 | 22.49 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 424.1925 | 20.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 424.3549 | 23.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 424.3553 | 23.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 424.3893 | 23.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 425.1630 | 22.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.1194 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.1195 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.1231 | 17.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.1244 | 16.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.1715 | 14.9 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.2053 | 17.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.2063 | 16.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.2077 | 18.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.2080 | 19.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.2515 | 20.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.2547 | 21.66 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 426.3638 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 427.0427 | 0.96 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 427.1776 | 22.93 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.0664 | 2.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.0788 | 7.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.1084 | 6.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.1464 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.1699 | 22.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.1900 | 16.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 428.2924 | 21.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 429.2878 | 20.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 430.0598 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | CORTISONE (M+Cl) | 430.1315 | 13.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 430.1626 | 16.55 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 430.3045 | 21.93 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 430.3069 | 21.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 430.3078 | 20.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.1149 | 3.76 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.1370 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.1373 | 4.39 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.2501 | 19.88 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.3022 | 23.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.3234 | 22.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 432.3353 | 22.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 434.0934 | 7.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 434.1380 | 15.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 434.3003 | 21.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 434.3380 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 434.3558 | 23.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 434.3747 | 23.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 435.1154 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 435.2767 | 22.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.0408 | 13.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.0726 | 8.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.1509 | 18.59 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.1525 | 14.73 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.1527 | 16.19 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.1534 | 17.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.2100 | 23.02 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.2812 | 20.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.2818 | 19.6 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.2821 | 19.68 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.2824 | 21.44 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.2827 | 21.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.3181 | 22.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.3528 | 23.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 436.3555 | 23.51 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 437.1316 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 437.1524 | 2.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 438.1524 | 9.24 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 438.1536 | 12 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 438.3386 | 22.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 438.3635 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 438.3692 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 438.3705 | 23.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 439.1485 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.0721 | 1.3 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.0894 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.1014 | 13.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.1138 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.3424 | 22.31 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.3487 | 22.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 440.3848 | 22.78 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 442.0916 | 4.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 442.0950 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 442.2485 | 20.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 442.3054 | 22.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 443.1130 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 443.9740 | 17.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 444.0511 | 8.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 444.1113 | 2.48 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 444.1854 | 13.09 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 444.2509 | 21.4 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 444.3246 | 22.83 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 445.1443 | 0.97 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 445.2815 | 18.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 445.3678 | 23.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 445.9858 | 3.41 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.1059 | 11.97 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.1059 | 13.5 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.1065 | 8.42 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.1244 | 18.94 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.1494 | 3.61 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.2670 | 21.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.2995 | 22.46 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.3395 | 22.92 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 446.3498 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 447.2988 | 17.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 447.2989 | 20.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 447.2994 | 20.43 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 448.2467 | 21.8 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 448.3158 | 22.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 448.3513 | 24.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 448.3531 | 22.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 450.1324 | 13.05 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 450.1527 | 22.57 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 450.3323 | 22.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 450.3685 | 23.13 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 451.1754 | 22.7 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 451.2709 | 22.25 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 451.9167 | 0.52 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.1481 | 11.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.2238 | 21.27 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.2762 | 20.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.3134 | 21.84 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.3480 | 22.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.3847 | 24.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.3851 | 23.34 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 452.3853 | 23.28 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 453.1840 | 3.62 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 453.1931 | 22.91 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 453.9552 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 454.1536 | 17.65 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 454.2193 | 18.15 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 454.2403 | 21.67 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 454.3268 | 22.75 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 454.3650 | 22.38 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 455.2026 | 4.08 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 455.2092 | 23.18 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 456.3419 | 22.45 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 457.9656 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 458.1842 | 22.82 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 458.2655 | 21.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 458.2663 | 20.86 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 458.3361 | 22.85 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 460.3518 | 24.58 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 461.1690 | 13.2 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 461.2316 | 1.56 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 462.1674 | 18.07 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | DEOXYCHOLIC ACID (M+Cl) | 462.2316 | 21.72 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
| AN001552 | 462.2984 | 21.74 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 462.3329 | 22.22 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 462.3670 | 24.69 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 463.0257 | 0.98 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 463.2929 | 17.04 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 463.2932 | 17.77 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 463.2935 | 16.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 463.2939 | 19.06 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 463.9827 | 5.53 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 464.0565 | 6.71 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 464.0566 | 8.63 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 464.1867 | 17.65 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 464.2394 | 18.17 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood | |
| AN001552 | 464.2747 | 21.89 | Minutes | ST000946 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Blood |
